Estudo sobre a resistência aos antimicrobianos em bactérias isoladas de pacientes hospitalizados (Botucatu, 1988-1992)
Nenhuma Miniatura disponível
Data
1996-09-01
Autores
Montelli, Augusto Cezar [UNESP]
Watanabe, Dard S. A. Aoki [UNESP]
Michelin, Lourival Antônio [UNESP]
Sadatsune, Terue [UNESP]
Título da Revista
ISSN da Revista
Título de Volume
Editor
Resumo
Since 1988 to 1992, a study about susceptibility to antimicrobial drugs of bacterias isolated from hospitalized patients was performed. The compared susceptibility to important drugs (ampicilin, cephalothin, cefoxitin, ceftazidime, ceftriaxone, aztreonam, gentamicin, amikacin, peftoxacin, ciprofloxacin, imipenem, oxacillin and vancomicin) was investigated in 1200 strains (300 of each specie) of the prevalent bacterias: E. coli, Klebsiella pneumoniae, Pseudomonas aeruginosa and S. aureus. Minimal inhibitory concentration (MIC) was determined by agar dilution method, using from 0,05 to 256 mcg of each drug per ml of culture medium (Mueller-Hinton). Ranges of MIC, MIC 50%, MIC 90% and the proportion of resistant strains were determined and permited to know the 4 drugs that were found to be more active against bacterias; the CIM 90% values are: E. coli - aztreonam (0,1 mcg/ml), pefloxacin (0,1), ceftazidime (0,25) and ceftriaxone (0,05); K. pneumoniae - aztreonam (0,25), ceftriaxone (0,25), ceftazidime (0,5) and pefloxacin (2,0); P. aeruginosa - imipenem (4,0), aztreonam (16), ceftazidime (16) and ciprofloxacin (16); S. aureus - vancomicina (1,0), ciprofloxacin (8,0), arnicacina (128) and cephalothin (128 mg/ml). The better in vitro antibacterial activity observed was related to: aztreonam (77-100% of the sensitive strains), ceftazidime (50-99,7%), pefloxacin (73-99,7%), ciprofloxacin(80%), imipenem (93%) and vancomicin (100%).
Descrição
Palavras-chave
antimicrobial drugs, bacterial sensitivity, hospital infection, amikacin, ampicillin, antibiotic agent, aztreonam, cefalotin, cefoxitin, ceftazidime, ceftriaxone, ciprofloxacin, gentamicin, imipenem, oxacillin, pefloxacin, vancomycin, antibiotic resistance, antibiotic sensitivity, controlled study, escherichia coli, hospital, human, klebsiella pneumoniae, minimum inhibitory concentration, nonhuman, pseudomonas aeruginosa, staphylococcus aureus
Como citar
Revista Brasileira de Medicina, v. 53, n. 9, p. 963-969, 1996.